Glucose transporter 1 deficiency, AMP-activated protein kinase activation and immune dysregulation in autism spectrum disorder: Novel biomarker sources for clinical diagnosis

Widad M. Al-Bishri

doi:10.1016/j.sjbs.2023.103849

Citations

392

Views

Abstract not available for this publication.

Cite this Article (APA)

Widad, M. A. (2023). Glucose transporter 1 deficiency, AMP-activated protein kinase activation and immune dysregulation in autism spectrum disorder: Novel biomarker sources for clinical diagnosis. Saudi Journal of Biological Sciences. https://doi.org/10.1016/j.sjbs.2023.103849

Md. Abdus Salam; Md. Yusuf Al-Amin; Jogendra Singh Pawar; Naseem Akhter; Irine B · 2023

159

cites

397

Molecular dynamics and simulation analysis against superoxide dismutase (SOD) target of Micrococcus …

Zabin K. Bagewadi; T.M. Yunus Khan; Bhavya Gangadharappa; Ankita Kamalapurkar; S · 2023

134

cites

397

Antimicrobial resistance in methicillin-resistant staphylococcus aureus

Bandar Ali Alghamdi; Intisar Al-Johani; Jawhra M. Al-Shamrani; Hussein Musamed A · 2023

127